Logo image of BGSF

BGSF INC (BGSF) Stock Fundamental Analysis

USA - NYSE:BGSF - US05601C1053 - Common Stock

7.21 USD
+0.14 (+1.98%)
Last: 9/18/2025, 8:04:00 PM
7.3575 USD
+0.15 (+2.05%)
Pre-Market: 9/19/2025, 9:04:54 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BGSF. BGSF was compared to 82 industry peers in the Professional Services industry. While BGSF seems to be doing ok healthwise, there are quite some concerns on its profitability. BGSF has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BGSF had negative earnings in the past year.
BGSF had a positive operating cash flow in the past year.
In multiple years BGSF reported negative net income over the last 5 years.
BGSF had a positive operating cash flow in 4 of the past 5 years.
BGSF Yearly Net Income VS EBIT VS OCF VS FCFBGSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.17%, BGSF is doing worse than 71.95% of the companies in the same industry.
The Return On Equity of BGSF (-7.97%) is worse than 65.85% of its industry peers.
Industry RankSector Rank
ROA -4.17%
ROE -7.97%
ROIC N/A
ROA(3y)1.7%
ROA(5y)3.14%
ROE(3y)3.07%
ROE(5y)5.95%
ROIC(3y)N/A
ROIC(5y)N/A
BGSF Yearly ROA, ROE, ROICBGSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

In the last couple of years the Operating Margin of BGSF has declined.
The Gross Margin of BGSF (33.79%) is comparable to the rest of the industry.
BGSF's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BGSF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.79%
OM growth 3Y-44.52%
OM growth 5Y-33.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y1.42%
BGSF Yearly Profit, Operating, Gross MarginsBGSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

BGSF does not have a ROIC to compare to the WACC, probably because it is not profitable.
BGSF has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BGSF has been increased compared to 5 years ago.
BGSF has a better debt/assets ratio than last year.
BGSF Yearly Shares OutstandingBGSF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BGSF Yearly Total Debt VS Total AssetsBGSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.34 indicates that BGSF is not a great score, but indicates only limited risk for bankruptcy at the moment.
BGSF's Altman-Z score of 2.34 is in line compared to the rest of the industry. BGSF outperforms 41.46% of its industry peers.
BGSF has a debt to FCF ratio of 3.90. This is a good value and a sign of high solvency as BGSF would need 3.90 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.90, BGSF is in line with its industry, outperforming 57.32% of the companies in the same industry.
BGSF has a Debt/Equity ratio of 0.55. This is a neutral value indicating BGSF is somewhat dependend on debt financing.
BGSF's Debt to Equity ratio of 0.55 is in line compared to the rest of the industry. BGSF outperforms 46.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.9
Altman-Z 2.34
ROIC/WACCN/A
WACC8.52%
BGSF Yearly LT Debt VS Equity VS FCFBGSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

BGSF has a Current Ratio of 1.64. This is a normal value and indicates that BGSF is financially healthy and should not expect problems in meeting its short term obligations.
BGSF has a Current ratio of 1.64. This is in the better half of the industry: BGSF outperforms 65.85% of its industry peers.
BGSF has a Quick Ratio of 1.64. This is a normal value and indicates that BGSF is financially healthy and should not expect problems in meeting its short term obligations.
BGSF has a better Quick ratio (1.64) than 67.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
BGSF Yearly Current Assets VS Current LiabilitesBGSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. Growth

3.1 Past

BGSF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -252.38%.
Looking at the last year, BGSF shows a very negative growth in Revenue. The Revenue has decreased by -24.36% in the last year.
BGSF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.39% yearly.
EPS 1Y (TTM)-252.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)-24.36%
Revenue growth 3Y4.47%
Revenue growth 5Y4.39%
Sales Q2Q%-65.5%

3.2 Future

BGSF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 95.35% yearly.
Based on estimates for the next years, BGSF will show a very negative growth in Revenue. The Revenue will decrease by -41.07% on average per year.
EPS Next Y119.9%
EPS Next 2Y95.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.22%
Revenue Next 2Y-41.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BGSF Yearly Revenue VS EstimatesBGSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BGSF Yearly EPS VS EstimatesBGSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

BGSF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 9.68, which indicates a very decent valuation of BGSF.
Based on the Price/Forward Earnings ratio, BGSF is valued cheaper than 86.59% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. BGSF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.68
BGSF Price Earnings VS Forward Price EarningsBGSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BGSF is valued a bit more expensive than the industry average as 70.73% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, BGSF is valued cheaper than 92.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.74
EV/EBITDA 45.69
BGSF Per share dataBGSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BGSF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BGSF's earnings are expected to grow with 95.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y95.35%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BGSF!.
Industry RankSector Rank
Dividend Yield N/A

BGSF INC

NYSE:BGSF (9/18/2025, 8:04:00 PM)

Premarket: 7.3575 +0.15 (+2.05%)

7.21

+0.14 (+1.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-07 2025-08-07/dmh
Earnings (Next)11-04 2025-11-04
Inst Owners32.1%
Inst Owner Change3.31%
Ins Owners3.8%
Ins Owner Change4.08%
Market Cap80.46M
Analysts85.71
Price Target10.71 (48.54%)
Short Float %0.39%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.15
Dividend Growth(5Y)-31.61%
DP0.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.83%
Min EPS beat(2)-1.96%
Max EPS beat(2)37.61%
EPS beat(4)1
Avg EPS beat(4)-67.96%
Min EPS beat(4)-162.39%
Max EPS beat(4)37.61%
EPS beat(8)2
Avg EPS beat(8)-64.49%
EPS beat(12)5
Avg EPS beat(12)31.57%
EPS beat(16)9
Avg EPS beat(16)37.58%
Revenue beat(2)0
Avg Revenue beat(2)-27.45%
Min Revenue beat(2)-49.9%
Max Revenue beat(2)-4.99%
Revenue beat(4)0
Avg Revenue beat(4)-17.12%
Min Revenue beat(4)-49.9%
Max Revenue beat(4)-4.99%
Revenue beat(8)0
Avg Revenue beat(8)-11.08%
Revenue beat(12)2
Avg Revenue beat(12)-6.75%
Revenue beat(16)4
Avg Revenue beat(16)-9.64%
PT rev (1m)-8.7%
PT rev (3m)5%
EPS NQ rev (1m)33.33%
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.88%
Revenue NQ rev (1m)-35.27%
Revenue NQ rev (3m)-52.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-30.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.68
P/S 0.36
P/FCF 6.74
P/OCF 6.39
P/B 1.03
P/tB 1.1
EV/EBITDA 45.69
EPS(TTM)-0.32
EYN/A
EPS(NY)0.74
Fwd EY10.33%
FCF(TTM)1.07
FCFY14.84%
OCF(TTM)1.13
OCFY15.65%
SpS19.92
BVpS7.01
TBVpS6.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.17%
ROE -7.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.79%
FCFM 5.37%
ROA(3y)1.7%
ROA(5y)3.14%
ROE(3y)3.07%
ROE(5y)5.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.81%
ROCE(5y)9.06%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-44.52%
OM growth 5Y-33.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y1.42%
F-Score3
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.9
Debt/EBITDA 16.3
Cap/Depr 14.93%
Cap/Sales 0.29%
Interest Coverage N/A
Cash Conversion 479.95%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 2.34
F-Score3
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)64.81%
Cap/Depr(5y)64.81%
Cap/Sales(3y)1.11%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y119.9%
EPS Next 2Y95.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.36%
Revenue growth 3Y4.47%
Revenue growth 5Y4.39%
Sales Q2Q%-65.5%
Revenue Next Year-32.22%
Revenue Next 2Y-41.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-118.87%
EBIT growth 3Y-42.04%
EBIT growth 5Y-30.19%
EBIT Next Year888.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y318.98%
FCF growth 3Y87.31%
FCF growth 5Y7.66%
OCF growth 1Y94.05%
OCF growth 3Y54.12%
OCF growth 5Y6.31%